register

News & Trends - Medical Technology

Doctors call for immediate action on diabetes glucose monitoring

Health Industry Hub | August 1, 2022 |
[Total: 2    Average: 4.5/5]

MedTech News: On 1 July 2022, access to subsidised continuous glucose monitoring (CGM) and Flash GM products for patients with Type 1 Diabetes Mellitus (T1DM) was expanded via the National Diabetes Services Scheme (NDSS) extending to Dexcom products (AMSL), Medtronic products and FreeStyle Libre products (Abbott Diabetes Care).

The Royal Australian College of General Practitioners (RACGP) has called for GPs to be allowed to approve access to subsidised glucose monitors for their patients.

In a letter to Penny Shakespeare, Deputy Secretary Health Resourcing, Australian Department of Health and Aged Care, the RACGP has strongly urged the Government to recognise that managing patients with type 1 diabetes within a specialist team is well within the scope of GPs across Australia.

RACGP President Adj. Professor Karen Price called for common sense to prevail.

“It is nonsensical that GPs can’t approve glucose monitors,” she said.

“The situation is that to apply for a subsidised continuous glucose monitoring product, the patient must fill out a form. This completed form must be certified by an authorised health professional whose usual scope of practice includes the ongoing management and care of people with type 1 diabetes.

“The NDSS outlines that health professionals authorised to certify continuous and flash glucose monitoring access forms are those for whom diabetes is the main scope of their practice. The access form and FAQs specify that ‘NDSS cannot approve forms that have been certified by GPs’ and that ‘this is an Australian Government policy decision’.”

The Department of Health and Aged Care stated that the decision, to exclude GPs from the authorised certifier group, has been based on expert advice from the Australian Diabetes Society and the Australian Diabetes Educators Association.

The RACGP is disappointed that they were not consulted and is calling for immediate action.

“So, clearly this policy decision needs to be reviewed and rectified right away. The RACGP calls on the Government to reconsider and recognise that managing patients with diabetes within a specialist team falls squarely within the job description of GPs,” she said.

“There is no logical explanation for why other members of a healthcare team are able to sign a form approving this device, but hardworking GPs are excluded. Not only is it insulting to GPs, it creates an unnecessary barrier to patient access for something that could make a real difference in managing their health. The status quo is particularly disadvantageous for patients in rural and remote areas who rely more on their GP for overall healthcare needs. Telehealth and electronic form transmission may be helpful for some but Medicare rebates for longer phone consultations were removed at the start of this month – something else we are trying to fix.

“GPs are there for our patients managing their diabetes, and the Government needs to be there for us. Let’s chart a new course on approving glucose monitors and ensure that the role of general practice is always kept front of mind.”

The Health Industry Hub content is copyright protected and access is provided under individual user licenses. For more information, click here and visit T&Cs here.


Human Resources

New gender pay gap data highlights disproportionate impact of inflation on Australian women

Health Industry Hub | August 19, 2022 |

Human Resources: Men are earning an average of $263.90 more than women a week, according to the latest gender pay gap data. […]

More


News & Trends - Medical Technology

MedTech News -

MedTech partnership to support brain and spine therapy in Asia Pacific region

Health Industry Hub | August 19, 2022 |

MedTech News: A new medtech partnership will support specialist physicians from across the Asia-Pacific region and pioneer new precision approaches […]

More


News & Trends - Pharmaceuticals

Consumer Health Forum and Patient Voice Initiative join Medicines Australia in voicing priorities for NMP Review restart

Health Industry Hub | August 19, 2022 |

Pharma News: Medicines Australia welcomes the restart of the National Medicines Policy (NMP) Review, which was put on hold prior […]

More


News & Trends - Pharmaceuticals

First public hospital to launch e-prescriptions in changing the dynamics of how patients access medicines

Health Industry Hub | August 19, 2022 |

Pharma News: In a first for public hospitals nationally, patients at Royal Perth Hospital can now obtain electronic prescriptions that […]

More


This content is copyright protected